D1 receptor; PKC-; oximal tubule; sodium homeostasis DOPAMINE REGULATES sodium homeostasis through inhibition of Na ϩ -K ϩ -ATPase and sodium hydrogen exchanger-3 (NHE-3) in renal proximal tubules thereby reducing transepithelial sodium reabsorption (1, 11) . Dopamine promotes internalization of Na ϩ -K ϩ -ATPase through clathrin-mediated endocytosis triggered by PKC--mediated phosphorylation of Na ϩ -K ϩ -ATPase ␣-subunit (4, 5, 10, 25) . Similarly, we have demonstrated that PTH inhibits the activity of Na ϩ -K ϩ -ATPase by clathrin-coated endocytosis triggered by PKC␣-mediated phosphorylation of the Ser-11 on the Na ϩ -K ϩ -ATPase ␣1-subunit (16) . We have also demonstrated that PTH-mediated regulation of Na ϩ -K ϩ -ATPase requires expression of an intact PDZ (postsynaptic protein PSD-95/SAP90, Drosophila septate junction protein Discs-large, tight junction protein ZO-1) protein NHERF-1 (18) . NHERF-1 contains two (PDZ-1 and PDZ-2) domains and a COOH-terminal ezrin-binding domain (EBD) . Mutations in the PDZ-1 domain of NHERF-1 or deletion of EBD result in loss of PTH-mediated regulation of Na ϩ -K ϩ -ATPase (18) . Recently, Chen et al. (3) demonstrated that Pals-associated tight junction protein (PATJ) functionally interacts with dopamine, angiotensin II, and insulin receptors in opossum kidney (OK) cells to regulate Na ϩ -K ϩ -ATPase activity. A recent study by Weinman et al. (28, 33) demonstrated that dopamine 1 receptor (D1-like receptor) binds to NHERF-1 to decrease sodium phosphate cotransporter in mice. These studies highlight the importance of protein-protein interactions that can organize large signaling complexes required for the regulation of sodium transport in the proximal tubules. PDZ containing proteins can provide the platform for formation of such large signaling complexes.
In the present study we focused on NHERF-1 as a potential scaffold for the dopamine-stimulated responses to regulate Na ϩ -K ϩ -ATPase in a proximal tubule cell culture model, the OK cells. NHERF-1 is highly expressed in renal proximal tubules and has been demonstrated to be important for expression and regulation of several renal proximal tubular ion transporters such as the sodium-phosphate cotransporter (NpT2a, 8, 15, 20, 29) , NHE-3 (9, 27, 30, 35) , the bicarbonate exchanger (NBCe-1, 2), and Na ϩ -K ϩ -ATPase (18) and several G protein-coupled receptors (21, 22, 31) . Our data demonstrate that NHERF-1 association with the D1 receptor increases while association between NHERF-1 and Na ϩ -K ϩ -ATPase decreases with dopamine treatment. Additionally, we found that expression of an intact PDZ-2 domain is important for the association between NHERF-1 and D1 receptor and the regulation of Na ϩ -K ϩ -ATPase by dopamine.
EXPERIMENTAL METHODS
Materials. Dopamine (3-hydroxytyramine-HCl, DA) was purchased from Calbiochem, La Jolla, CA. Polyclonal antibodies against Na ϩ -K ϩ -ATPase ␣1-subunit (RT-NASE, for immunoprecipitation) were kindly provided by Dr. Thomas Pressley (Texas Tech University, Lubbock, TX). Monoclonal D1 receptor antibodies (DRD1A, cat. no. MA1-46024) were purchased from Thermo Fisher (Pittsburgh, PA). PKC activity kit was purchased from Millipore (Waltham, MA). Monoclonal antibodies against Na ϩ -K ϩ -ATPase ␣1-subunit (␣6F, for Western blot analyses) developed by Dr. D. M. Fambrough were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of NIHCD and maintained by the University of Iowa, Department of Biological Sciences (Iowa City, IA). Phosphoserine antibodies were purchased from Zymed (San Francisco, CA). Fig. 1 . Effect of dopamine on association of Na ϩ -K ϩ -ATPase ␣1-subunit with NHERF-1. A: wild-type (WT) opossum kidney (OK) cells were treated for 15 min with 1 M dopamine at 37°C. Na ϩ -K ϩ -ATPase ␣1-subunit (A) or NHERF-1 (B) was immunoprecipitated from crude membranes and analyzed by Western blot analysis using antibodies against AP2, Rab5, NHERF-1, or Na ϩ -K ϩ -ATPase ␣1-subunit. Bar diagram shows cumulative data from three individual experiments as arbitrary units (A.U.) means Ϯ SE ratio of protein to Na ϩ -K ϩ -ATPase ␣1-subunit band density. *P Ͻ 0.05 by ANOVA followed by Bonferroni's analysis from vehicle-treated cells. C: WT OK cells were treated for 5 or 15 min with 1 M dopamine at 37°C. Cells were fixed and expression of NHERF-1 (green fluorescence) and Na ϩ -K ϩ -ATPase ␣1-subunit (red fluorescence) was determined by confocal microscopy. Representative images from three independent experiments are shown. Arrows indicate separation of NHERF-1 from Na ϩ -K ϩ -ATPase ␣1-subunit after dopamine treatment.
Anti-NHERF-1 antibodies were previously characterized by Weinman and his colleagues (32) . NHERF-1 mutations. NHERF-1 mutations were previously described by Dr. Weinman and his colleagues (34) . Briefly, the human NHERF-1 cDNA was inserted into pET-30-(a) ϩ (Novagen) to generate a hexahistidine-fused NHERF-1 (His-NHERF-1), which was then transferred to pcDNA3.1/Hygro ϩ for expression in mammalian cells. Similarly, cDNAs encoding NHERF-1 with alanine substitutions (GAGA) in the core peptide-binding sequence GYGF (AA 77-82 PDZ-1, and 217-222 PDZ-2), which inactivates the individual PDZ domains, were inserted into pcDNA3.1/Hygro ϩ . All cDNAs were confirmed by double-stranded DNA sequencing.
Cell culture. The OK cells are a continuous cell line derived from Virginia opossum and a widely used model for mammalian renal proximal tubule (34) . OKH cells are a clonal subline of the parental OK cell line that lacks the expression of NHERF-1 (7, 20, 23) . Vector (pcDNA 3.1Hygro ϩ )-transfected, OK-WT and OKH cells, and OKH cells stably transfected with human full-length, or PDZ domains mutated NHERF-1 [hNHERF-1 (1-355)], were maintained at 37°C in a humidified atmosphere with 5% CO 2 in DMEM/F12 medium (1:1) supplemented with 10% vol/vol FBS, penicillin (100 U/ml), streptomycin (100 g/ml), in the presence of 600 U/ml hygromycin. The cells were fed twice a week and split once a week at 1:4 ratio. All experiments were carried out using cells at 90 -95% confluence. Cells grown on six-well culture plates were washed with serum-free medium 24 h before use.
NHERF-1 cDNA transfection. Vector (pcDNA 3.1Hygro ϩ ) or human NHERF-1 and PDZ-mutated human NHERF-1 cDNA constructs in pcDNA 3.1Hygro ϩ was transfected into OKH cells using
Geneporter transfection reagent according to the manufacturer's protocol. Briefly, the cDNA and the Geneporter reagent were diluted separately in serum-free medium. The diluted cDNA was mixed with diluted Geneporter reagent and incubated at room temperature for 30 min. The culture medium from the cells was replaced with the mixture containing Geneporter and NHERF-1 cDNA and incubated for 24 h at 37°C in 95% air-5% CO2. The transfected cells were selected by growing them in 1,000 U/ml hygromycin in a 96-well cell culture plate for 2 wk. Cells from the hygromycin-resistant wells were grown in DMEM F-12 containing 600 U/ml hygromycin and 10% FBS. Expression of NHERF-1 was confirmed by Western blot analysis (18) . Treatment with dopamine. Unless otherwise stated, cells were treated for 15 min with 1 M 3-hydroxytyramine-HCl (dopamine) at 37°C in 95% air-5% CO2.
Membrane preparation. The cells were treated with 1 M dopamine or vehicle, washed twice with PBS, and homogenized in 50 mM mannitol-5 mM Tris, pH 7.4, and the crude membranes were prepared as described previously (19) .
Immunoprecipitation. The crude membranes were solubilized in immunoprecipitation buffer containing 20 mM Tris · HCl, pH 7.4, 150 mM NaCl, 20 mM NaF, 1 mM EDTA, 1 mM EGTA, 5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF), 1 mM sodium pyrophosphate, 1 g/ml aprotinin, 1 g/ml leupeptin, 1% Triton X-100, 0.5% Nonidet 40, and 0.5% SDS, and centrifuged at 70,000 g for 1 h in Beckman ultracentrifuge. Na ϩ -K ϩ -ATPase ␣1-subunit was immunoprecipitated from 100-g supernatant protein overnight at 4°C as described previously (17) . Western blotting was performed as previously reported (19) . (17) and translocation of PKC-␣, -␤, and -were analyzed by Western blot analysis. Representative Western blots of membrane fractions from three independent experiments are shown. Bar diagram represent data from three independent experiments as A.U. means Ϯ SE ratio of PKC band density to actin band density. B: Na ϩ -K ϩ -ATPase ␣1-subunit was immunoprecipitated and analyzed by Western blot analysis using antibodies against phosphoserine, PKC-␤1, or PKC-. Representative Western blots from three independent experiments are shown. Bar diagram represent data from three independent experiments as A.U. means Ϯ SE ratio of phosphoserine or PKC band density to Na ϩ -K ϩ -ATPase ␣1-subunit band density. *P Ͻ 0.05 by ANOVA followed by Bonferroni's analysis from vehicle-treated cells. , or Na ϩ -K ϩ -ATPase ␣1-subunit (C) was immunoprecipitated and analyzed by Western blot analysis using antibodies against D1 receptor, NHERF-1, Na ϩ -K ϩ -ATPase ␣1-subunit, or PKC-. A representative blot from three independent experiments is shown. Bar diagram represent data as A.U. means Ϯ SE from three independent experiments. *P Ͻ 0.05 by ANOVA followed by Bonferroni's analysis from the respective vehicle-treated cells.
Western blot, Na
ϩ -K ϩ -ATPase activity, and 86 Rb uptake. Western blot analysis for NHERF-1, Na ϩ -K ϩ -ATPase ␣1-subunit, and PKCwas performed exactly as previously described (19) . Na ϩ -K ϩ -ATPase activity as K ϩ -dependent pNPPase activity was measured according to the method of Hird et al. (12) with slight modifications as described previously (19) . Ouabain-sensitive 86 Rb uptake was measured as described previously (17) .
Confocal imaging. Multichambered coverglass wells (Nunc) were seeded with OK cells. Cells were washed with serum-free medium 24 h and treated with 1 M DA for 15 min before fixation. Cells were rinsed three times with PBS containing calcium and magnesium, incubated in 4% paraformaldehyde in PBS for 10 min, rinsed five times with PBS, solubilized with 0.025% saponin in PBS for 15 min, incubated with an appropriate dilution of primary antibody (1:250 in PBS-Saponin for both NHERF-1 and Na ϩ -K ϩ -ATPase ␣1 subunit antibodies) at 20°C, rinsed five times with PBS-saponin, and incubated with appropriate Alexafluor secondary antibody (1:1,000) conjugated to different fluorescent tags at 20°C. Anti-rabbit antibodies attached to Alexafluor 488 were used for identification of NHERF-1 and anti-mouse antibodies attached to Alexafluor 555 for identification of the ␣-subunit. The cells were rinsed five times with PBSsaponin, incubated with 300 nM DAPI for 5 min, rinsed three times with PBS, and mounted with 300 l/well PBS. Images were acquired using a Zeiss confocal microscope and analyzed using LSM510 software. Z-scan analysis on single cells was performed by scanning at 1-m intervals and three-dimensional reconstruction of the fluorescent images. The images for NHERF-1 and ␣-subunit were merged in a single image to compare the cellular distribution of the two proteins.
Determination of PKC and PKA activities. Cells were treated with 1 M DA for 15 min, washed two times with PBS, pH 7.4, and lysed in lysis buffer containing 20 mM Tris, pH 7.4, 150 mM NaCl, 20 mM NaF, 1 mM EGTA, 1 mM EDTA, 10 l/ml protease inhibitor cocktail 1, 10 l/ml phosphatase inhibitor cocktail 1, 0.5% Nonidet-40, and 1% Triton X-100. The lysates were sonicated on ice for 15 s three times with an interval of 15 s in between each sonication pulse. PKC activity was determined according to the manufacturer's protocol (Upstate Biotechnology, Waltham, MA) and as described previously (17) . Briefly, 10 l each of assay dilution buffer (ADB; 20 mM MOPS, pH 7.2, 25 mM ␤-glycerol phosphate, 1 mM sodium orthovanadate, 1 mM dithiothreitol, and 1 mM CaCl 2), substrate cocktail (500 M PKC substrate), PKA/CaMK inhibitor cocktail (2 M protein kinase A inhibitor peptide PKI, and 20 M R24571 in ADB), PKC lipid activator (0.5 mg/ml phosphatidyl serine and 0.05 mg/ml diacylglycerol in ADB), and magnesium/ATP cocktail (75 mM MgCl 2, 500 M ATP, and 100 Ci [␥-
32 P]ATP) were added to the 10-l sample (25-30 g protein) and incubated at 30°C for 10 min. PKA activity was determined as incorporation of radioactive phosphate to PKA substrate peptide kemptide in the presence or absence of 2 M protein kinase A inhibitor peptide PKI. Briefly, to 30 l of assay buffer (25 mM HEPES, pH 7.4, 20 mM MgCl 2, 20 mM ␤-glycerol phosphate, 0.1 mM sodium orthovanadate, 2 mM dithiothreitol, and 10 M PKC inhibitory peptide, 20 M CaMK inhibitor R24571, 500 M ATP, and 100 Ci [␥-32 P]ATP), 10 l PKA substrate peptide (600 M kemptide, final concentration), 2 M PKI or vehicle, a 10 l sample (25-30 g protein) was added and incubated at 30°C for 10 min. After 10 min a 25-l sample was slowly transferred to the center of a P81 phosphocellulose paper and incubated at room temperature for 30 min. The P81 papers were washed three times with 0.75% phosphoric acid and once with acetone, dried, and transferred to scintillation vials. Bound radioactivity was quantitated by the addition of 3 ml of scintillation fluid and reading in a scintillation counter (Pharmacia). A substrate control was measured to correct for nonspecific binding along with the samples. Control counts were subtracted from the sample counts to calculate the PKC activity according to the manufacturer's protocol. To calculate PKA activity, control counts were subtracted from the sample counts, and the difference between total and PKI inhibitable counts were considered as PKA activity. The activities are expressed as pmoles phosphate incorporated into the PKC/PKA substrate peptide per minute per milligram protein.
Protein concentration was measured by BCA method (Sigma) using BSA as standard.
Statistics. Data are shown as means of three different experiments Ϯ SE. P value was calculated using GraphPad software utilizing ANOVA followed by Bonferroni analysis. A P value Ͻ0.05 was a priori considered statistically significant. ϩ -ATPase ␣ 1 -subunit with AP2 and Rab5 (4, 5, 10) . To determine whether dopamine regulates Na ϩ -K ϩ -ATPase ␣ 1 -subunit association with NHERF-1, OK-WT cells were treated for 15 min with 1 M dopamine at 37°C, and Na ϩ -K ϩ -ATPase ␣ 1 -subunit or NHERF-1 was immunoprecipitated using a polyclonal antibody against Na ϩ -K ϩ -ATPase ␣ 1 -subunit (RT-NASE) or a polyclonal antibody against NHERF-1. The immunoprecipitated proteins were separated by 10% SDS-PAGE, transferred to nitrocellulose membrane, and analyzed by Western blot analysis. As shown in Fig. 1A , treatment with dopamine increased association of Na ϩ -K ϩ -ATPase ␣ -subunit with AP-2 and Rab5. Similarly, treatment with dopamine increased association of NHERF-1 with AP2 and Rab5 (Fig. 1B) . However, treatment with dopamine decreased the association of Na ϩ -K ϩ -ATPase ␣ 1 -subunit with NHERF-1 (Fig. 1A) . Reciprocal immunoprecipitation with NHERF-1 confirmed decreased association of NHERF-1 with Na (Fig.  1B) . We confirmed the immunoprecipitation results by dual fluorescence confocal microscopy of cells treated for 5 and 15 min with 1 M dopamine. As shown in Fig. 1C , treatment with vehicle showed association of Na ϩ -K ϩ -ATPase ␣ 1 -subunit with NHERF. Treatment with dopamine for 5 or 15 min treatment resulted in dissociation of NHERF-1 from Na
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Effect of dopamine on Na
-subunit phosphorylation: role of PKC-.
To determine the specific PKC isoform activated by dopamine in OK cells, time-dependent translocation of PKC-␣, -␤1, or -from cytosol to membrane fraction was analyzed by Western blot analysis in dopaminetreated OK cells. As shown in Fig. 2A , treatment with dopamine increased membrane expression of PKC-as early as 2 min after treatment, and the expression remained increased for 30 min after treatment. The membrane expression of PKC-␤1 increased after 5 min treatment with dopamine, reached a maximum after 10 min of treatment, and remained increased for 30 min treatment. In contrast, dopamine increased membrane expression of PKC␣ only after 10 min treatment and returned to control levels after 15 and 30 min treatment. To correlate dopamine stimulated Na ϩ -K ϩ -ATPase ␣ 1 -subunit phosphorylation with PKC-translocation, Na ϩ -K ϩ -ATPase ␣ 1 -subunit was immunoprecipitated after 15 min treatment with dopamine and analyzed by Western blot analysis using phospho-serine antibody. As shown in Fig. 2B , treatment with dopamine increased Na ϩ -K ϩ -ATPase ␣ 1 -subunit phosphorylation. Dopamine treatment resulted in increased association of PKC-, but not PKC-␣ or -␤1, with Na (Fig. 2B) .
NHERF-1 association with Na
ϩ -K ϩ -ATPase ␣ 1
-subunit and dopamine 1 receptor (D1 receptor).
A recent report by Weinman et al. (28, 33) demonstrated that NHERF-1 co-immunoprecipitates with D1 receptor in mouse kidney proximal tubules. To determine the site on NHERF-1 responsible for interaction with D1 receptor, we used previously described OKH cells that express very low level of NHERF-1 and OKH cells stably transfected with full-length or PDZ domainsmutated human NHERF-1 (18) . Cells were treated with vehicle or 1 M dopamine, and D1 receptor was immunoprecipitated from crude membrane preparations and analyzed by Western blot anaylsis using NHERF-1 or Na ϩ -K ϩ -ATPase ␣ 1 -subunit antibodies. As shown in Fig. 3A, 15 (Fig. 3B) . To determine whether NHERF-1 binds to PKC-and Na ϩ -K ϩ -ATPase ␣ 1 -subunit, NHERF-1 was immunoprecipitated from vehicle or dopamine-treated cells and analyzed by Western blot analysis. As shown in Fig. 3B , treatment with dopamine increased NHERF-1 association with PKC-and D1 receptor in OK-WT cells but not in OKH cells. In contrast the NHERF-1-Na ϩ -K ϩ -ATPase ␣ 1 -subunit association decreased, consistent with the data in Fig. 1 . The same pattern of association was observed in OKH cells transfected with full-length or PDZ domain 1-mutated NHERF-1 but not in OKH cells transfected with mutated PDZ domain 2 (Fig. 3B) . Immunoprecipitation with antibodies against Na ϩ -K ϩ -ATPase ␣ 1 -subunit confirmed increased association of Na ϩ -K ϩ -ATPase ␣ 1 -subunit and D1 receptor with dopamine treatment (Fig. 3C) .
Role of NHERF-1 in dopamine-mediated regulation of Na
The above data suggest that both Na ϩ -K ϩ -ATPase ␣ 1 -subunit and NHERF-1 associate with D1 receptor in OK cells after dopamine treatment. However, the NHERF-1-Na ϩ -K ϩ -ATPase ␣ 1 -subunit association is decreased under the same conditions. To determine whether the changes in associations between NHERF-1-Na ϩ -K ϩ -ATPase ␣ 1 -subunit and NHERF-1 and D1 receptor are important for the dopamine-mediated inhibition of Na ϩ -K ϩ -ATPase activity, Na ϩ -K ϩ -ATPase activity was measured in crude membrane preparations isolated from OK-WT and OKH cells expressing NH-ERF-1. The ouabain-sensitive, K ϩ -dependent pNPPase Fig. 4 . Effect of NHERF-1 expression on dopamine-mediated Na ϩ -K ϩ -ATPase ␣1-subunit regulation. Vector-transfected WT and NHERF-1-deficient OK (OKH) cells, or OKH cells transfected with full-length NHERF-1 (NF), PDZ-1 (Z1)-mutated, or PDZ-2 (Z2)-mutated NHERF-1 were treated for 15 min with 1 M dopamine at 37°C. A: ouabain-sensitive K ϩ -pNPPase activity was measured as described previously (18) . Each bar represents activity as mean Ϯ SE (mole pNPP released · mg protein Ϫ1 · min Ϫ1 ) from four independent experiments. *P Ͻ 0.05 by ANOVA followed by Bonferroni's analysis from the respective vehicle-treated cells. B: ouabain-sensitive 86 Rb uptake was measured as described previously (18) . Each bar represents 86 Rb uptake as means Ϯ SE (nmole 86 Rb uptake · mg protein Ϫ1 · 10 min
Ϫ1
). *P Ͻ 0.05 by ANOVA followed by Bonferroni's analysis from the respective vehicle-treated cells. C: cells were lysed after treatment with dopamine as above. Na ϩ -K ϩ -ATPase ␣1-subunit was immunoprecipitated from crude membranes and analyzed by Western blot analysis using phosphoserine antibodies. Bar diagram represents data as A.U. (ratio of phosphoserine band density to Na ϩ -K ϩ -ATPase ␣1-subunit) means Ϯ SE from four independent experiments. *P Ͻ 0.05 by ANOVA followed by Bonferroni's analysis from the respective vehicle-treated cells. activity (Fig. 4A ) and ouabain-sensitive 86 Rb uptake (Fig.  4B ) was decreased in dopamine-treated OK-WT cells but not in NHERF-1-deficient OKH cells, indicating the requirement for NHERF-1 in dopamine-mediated inhibition of Na ϩ -K ϩ -ATPase activity. OKH cells transfected with full-length or PDZ-1 mutated NHERF-1 regained the dopamine inhibition of Na ϩ -K ϩ -ATPase activity. In contrast, dopamine had no effect on Na ϩ -K ϩ -ATPase-mediated pNPPase activity and 86 Rb uptake in OKH cells tranfected with mutated PDZ-2.
To determine whether NHERF-1 regulates dopamine-mediated phosphorylation of Na ϩ -K ϩ -ATPase ␣ 1 -subunit, the above cells were treated with 1 M dopamine, and Na ϩ -K ϩ -ATPase ␣ 1 -subunit was immunoprecipitated from crude membrane preparations and analyzed by Western blot using phospho-serine antibodies. As shown in Fig. 4C , treatment with dopamine increased phosphorylation of Na ϩ -K ϩ -ATPase ␣ 1 -subunit in vector-transfected OK-WT cells but not in vectortransfected OKH cells. Transfection with full-length or PDZ-1-mutated NHERF-1 in OKH cells restored dopamine-mediated phosphorylation of Na ϩ -K ϩ -ATPase ␣ 1 -subunit. In contrast, dopamine had no effect on Na ϩ -K ϩ -ATPase ␣ 1 -subunit phosphorylation in cells transfected with PDZ-2.
Role of NHERF-1 in dopamine-stimulated PKA and PKC activity. We have previously demonstrated that NHERF-1 is required for PTH-mediated stimulation of PKC activity in OK cells (18) . Recently, Weinman and colleagues (28) demonstrated that dopamine failed to activate PKC or PKA in kidney slices and proximal tubule cells from NHERF-1 knock-out mice. Therefore, we determined the specific PDZ domains of NHERF-1 critical for dopamine-mediated PKC and PKA activation. As shown in Fig. 5 , treatment of vector-transfected OK-WT cells with 1 M dopamine increased PKA (Fig. 5A) and PKC (Fig. 5B) activities. In contrast, dopamine had no effect on PKA and PKC activities in vector-transfected OKH cells. Transfection with NHERF-1 or NHERF-1 with a mutation in PDZ-1 domain in OKH cells restored dopamine-stimulated PKA and PKC activities but not in OKH cells transfected with NHERF-1 with mutations in PDZ-2.
DISCUSSION
Studies from several laboratories have established that dopamine regulates sodium reabsorption in the kidney proximal tubules primarily through activation of D1-like receptors (1) . We and others demonstrated that dopamine decreases Na ϩ -K ϩ -ATPase activity in OK cells through activation of PKA and PKC (10, 18) . The laboratories of Bertorello and Pedemonte demonstrated that dopamine through activation of PKC-phosphorylates Na ϩ -K ϩ -ATPase at serine-11 and -18 resulting in association with AP2, Rab5, and 14-3-3- (4, 5, 10, 26) . A recent report from Dr. Bertorello's laboratory (3) suggests that dopamine-mediated regulation of Na ϩ -K ϩ -ATPase ␣ 1 -subunit requires association with a six PDZ domain containing protein Pals with D1 receptors. Whereas the study suggested an important role for PDZ protein-mediated interactions in dopamine regulation of the sodium pump, the study was based on overexpression of a protein not normally expressed in OK cells. In contrast our study demonstrates the requirement for NHERF-1, an endogenously expressed PDZ domain containing protein in dopamine-mediated regulation of Na ϩ -K ϩ -ATPase. NHERF-1 is expressed in proximal tubules from human, mouse, rat, and opossum kidney and has been demonstrated to regulate the expression and trafficking of NpT2a (15, 28, 33) and regulation of NHE3 (30, 32, 34, 35) , NBCe1 (2), and Na (18) . Prior studies (21, 31 ) demonstrated that NHERF-1 can associate with several G protein-coupled receptors including PTH receptor, ␤ 2 -adrenergic receptor, and the -opioid receptor. A recent study by Weinman et al. (28) demonstrated that NHERF-1 associates with D1 receptor and that this association is critical for regulation of type IIa sodium-phosphate cotransporter in mouse proximal tubules. However, the role of NHERF-1 in dopaminemediated regulation of Na ϩ -K ϩ -ATPase ␣ 1 -subunit has not been explored. The present studies were conducted to identify the PDZ domain on NHERF-1 responsible for the association with D1 receptor and to determine whether the association between NHERF-1 and D1 receptor is required for dopaminemediated regulation of Na (18, 28) have previously demonstrated that NH-ERF-1 is required for receptor-mediated activation of downstream signaling cascades including PKA and PKC. The present study confirms that NHERF-1 is required for dopaminemediated regulation of Na ϩ -K ϩ -ATPase through activation of PKA and PKC, also through the PDZ-2 domain.
Unlike D1 receptor association with NHERF-1 and Na Weinman demonstrated that dopamine-induced PKC activation leads to phosphorylation of NHERF-1 at Ser77 (28, 33) . Whether NHERF-1 phosphorylation is responsible for decreased association between Na ϩ -K ϩ -ATPase ␣ 1 -subunit and NHERF-1 cannot be determined from our data. However, our data show an increase in association between PKC-and NHERF-1 suggesting that PKC-may phosphorylate NHERF-1. Further studies are required to confirm this observation.
Our studies further demonstrated that treatment with dopamine increased Na ϩ -K ϩ -ATPase ␣ 1 -subunit association with AP2 and Rab5. Using a PKC--specific peptide, Effendiev et al. (10) demonstrated that dopamine increases phosphorylation of Ser11 and Ser18 on Na Based on our data we speculate that NHERF-1 may stabilize Na ϩ -K ϩ -ATPase ␣ 1 -subunit in the membrane. Upon stimulation with dopamine, NHERF-1 may undergo phosphorylation resulting in its dissociation with Na ϩ -K ϩ -ATPase ␣ 1 -subunit thereby allowing phosphorylation of Na ϩ -K ϩ -ATPase ␣ 1 -subunit and association with AP2 and Rab5. Whether there exists a 1:1 relationship between the increased association between Na ϩ -K ϩ -ATPase ␣ 1 -subunit and NHERF-1 with D1R remains to be elucidated. However, our data suggest that there may not be 1:1 relationship between the interactions. In summary, the data presented in this study demonstrate novel interactions among D1 receptor, Na ϩ -K ϩ -ATPase ␣ 1 -subunit, PKC-, and NHERF-1 that are modulated by dopamine. The data further suggest that an intact PDZ-2 domain is required for this association and regulation of Na ϩ -K ϩ -ATPase by dopamine-mediated PKA and PKC activation in OK cells. These studies together with our previous studies (18) suggest that different NHERF-1 PDZ domains are required for stimulation of different PKC isoforms and that NHERF-1 may confer the specificity of different hormones to regulate Na ϩ -K ϩ -ATPase ␣ 1 -subunit in renal proximal tubule cells.
